Galen Partners closes $250M healthcare fund
Galen Partners, a Stamford, Conn., private-equity firm that concentrates solely on the healthcare industry, closed a $250 million fund, its fifth. The fund will focus on healthcare IT, medical devices and specialty pharmaceuticals.
Next Story: Noven Pharma to acquire JDS Pharma for $125M
Previous Story: NeoMend pulls together $6M for wound healing
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.